4
Changes in Ownership
Sana Biotechnology, Inc. Filed Acc 0001562180-24-002476
Options or other derivatives
- EVP, Chief Financial Officer acquired 368,958 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Hardy Nathan · EVP, Chief Financial Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-03-07 | Grant or award : show line 1 in the form Restricted Stock Units | +67,083 | 67,083 | D |
| 2024-03-07 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +301,875 | 301,875 | D |
Loading xslF345X05/primarydocument.xml…